As everyone else I appreciate your knowledgeable input bedger.
I have one genuine concern. Are there any, or do you or does anyone else know of alternative procedures that could be in direct
competition to Celgro and ATI/ACI in the short to medium term?
I know that Celgro has established competition in the dental bone graft field (albeit not as effective).
There is just this nagging thought in the back of my mind that there are alternatives therapies out there and that is why OCC can't gain much traction in the market or the medical profession.
I assure you I am not trying to downramp.I have too much invested in this company. This is really the only real concern I have about OCC.
Any other problems on the horizon will take care of themselves (with good management of course), because we have such remarkable products.
Cheers everyone.
- Forums
- ASX - By Stock
- OCC
- Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon, page-5
-
-
- There are more pages in this discussion • 214 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.5¢ |
Change
0.115(20.9%) |
Mkt cap ! $139.3M |
Open | High | Low | Value | Volume |
56.5¢ | 68.0¢ | 56.5¢ | $2.002M | 3.169M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | 66.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | 0.665 |
2 | 42825 | 0.660 |
1 | 825 | 0.655 |
1 | 10900 | 0.650 |
1 | 3200 | 0.645 |
Price($) | Vol. | No. |
---|---|---|
0.670 | 10000 | 1 |
0.680 | 53867 | 3 |
0.690 | 1000 | 1 |
0.695 | 29388 | 2 |
0.700 | 133501 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online